Microvascular Therapeutics (MVT) is a biotechnology company specializing in the development of microbubble and nanotechnology products for the diagnosis and treatment of disease...
MVT has developed a new, patented formulation, MVT-100, for use as an ultrasound contrast agent...
MVT-100 has a neutral surface chemistry, potentially serving as a platform for development of agents for molecular imaging and image-guided therapy. We've received formal guidance from the FDA that MVT-100 can be developed via the 505(b)(2) pathway.